⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

NUVAMA - Fundamental Analysis: Financial Health & Valuation

← Back to List

⭐ Rating: 2.3

Last Updated Time : 13 Sept 26, 12:11 am

Key Parameters

⭐ Fundamental Rating: 2.3

ROE28.2 %
ROCE23.7 %
Stock P/E53.5
Industry PE18.2
PEG Ratio0.15
Debt to equity0.53
EPS33.0 ₹
Book Value115 ₹
Show all parameters (20 more)
Stock CodeNUVAMA
Market Cap32,123 Cr.
Current Price1,737 ₹
High / Low2,067 ₹
Dividend Yield1.60 %
Face Value2.00 ₹
DMA 501,757 ₹
DMA 2001,571 ₹
Chg in FII Hold2.06 %
Chg in DII Hold0.19 %
PAT Qtr255 Cr.
PAT Prev Qtr19.1 Cr.
RSI44.1
MACD6.35
Volume2,50,850
Avg Vol 1Wk2,59,207
Low price1,097 ₹
High price2,067 ₹
52w Index66.0 %
Qtr Profit Var15.0 %

🏭 Industry

The wealth management industry is characterized by high competition and relatively thin margins, with profitability often tied to asset under management (AUM) growth and net new assets. Industry participants frequently operate with lower capital intensity than other financial sectors, but face intense scrutiny regarding regulatory compliance and investor protection.

✅ Positive

Nuvama’s recent PAT growth of 15% quarter-over-quarter indicates strong operational momentum and improved earnings quality, supported by a healthy ROCE of 23.7%. The company maintains a conservative debt-to-equity ratio of 0.53, providing financial flexibility and reducing credit risk.

⚠️ Limitation

Despite the robust recent profit growth, the exceptionally high P/E ratio of 53.5 relative to its industry peers (18.2) raises concerns about overvaluation, particularly considering the limited information available on future growth prospects. The reliance on promoter holdings for a significant portion of the share capital introduces potential liquidity and governance risks.

📉 Company Negative News

Recent news indicates that NSE Clearing rejected Nuvama’s appeal for penalty waiver, which could lead to additional legal expenses or adverse judgments, while also reporting promoter share encumbrance worth ₹174,238 crore.

🧾 Long-Term Outlook

We recommend a cautious entry zone around 1,500 - 1,600 ₹, acknowledging the elevated valuation. Long-term holding guidance focuses on monitoring AUM growth, maintaining consistent profitability margins above 20%, and diligent oversight of promoter ownership structures. The current stock is trading at a significant premium to its industry peers, suggesting moderate risk; however, continued strong financial performance is necessary for sustained value creation.

Choose Technical Analysis or Fundamental Analysis above to load it.

How NUVAMA Rates Across All Strategies

★ 2.8
Enter at 1,705₹ – a tactical dip from the current price offers an ent…
★ 2.3
Optimal Buy Price: 1705 ₹.
★ 2.3
An ideal entry zone would be between 1,500 ₹ and 1,650 ₹, exploiting…
Fundamental
★ 2.3
You're viewing this analysis below.

NIFTY 50 · Fundamental

NEXT 50 · Fundamental

MIDCAP · Fundamental

SMALLCAP · Fundamental